Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases

scientific article published on 13 August 2014

Gonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.RBMO.2014.07.022
P8608Fatcat IDrelease_3h7vqwbcqfbbbmahagkqiltmse
P698PubMed publication ID25246114

P2093author name stringAli Sami Gurbuz
Ahmet Zeki Isik
Necati Ozcimen
Funda Gode
P433issue5
P921main subjectovarian hyperstimulation syndromeQ1760461
P304page(s)541-544
P577publication date2014-08-13
P1433published inReproductive BioMedicine OnlineQ15762964
P1476titleGonadotrophin-releasing hormone agonist trigger and freeze-all strategy does not prevent severe ovarian hyperstimulation syndrome: a report of three cases
P478volume29

Reverse relations

cites work (P2860)
Q90259787A Second Dose of GnRHa in Combination with Luteal GnRH Antagonist May Eliminate Ovarian Hyperstimulation Syndrome in Women with ≥30 Follicles Measuring ≥11 mm in Diameter on Trigger Day and/or Pre-trigger Peak Estradiol Exceeding 10 000 pg/mL
Q38685318A fresh look at the freeze-all protocol: a SWOT analysis
Q46788717A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
Q38371465A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial
Q48566514Absence of luteal phase defect and spontaneous pregnancy in IVF patients despite GnRH-agonist trigger and "freeze all policy" without luteal phase support: a report of four cases
Q38829575An update on the prevention of ovarian hyperstimulation syndrome
Q37042732Avoiding OHSS: Controlled Ovarian Low-Dose Stimulation in Women with PCOS.
Q48510192Combined modalities for the prevention of ovarian hyperstimulation syndrome following an excessive response to stimulation.
Q43206166Does freeze all policy eliminate OHSS??? "It ain't necessarily so…".
Q36060453Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy
Q33770533GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis
Q28077044GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
Q88990735Gonadotropin-releasing hormone agonist triggering of oocyte maturation in assisted reproductive technology cycles
Q41223889Gonadotropin-releasing hormone agonist triggering with concomitant administration of low doses of human chorionic gonadotropin or a freeze-all strategy in high responders
Q36756209Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology?
Q58701046Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome
Q57177405Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment
Q35938164Ovarian hyperstimulation syndrome after gonadotropin-releasing hormone agonist triggering and "freeze-all": in-depth analysis of genetic predisposition
Q38876689Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials
Q33743109Pharmacokinetic, pharmacodynamic, and clinical aspects of ovulation induction agents: A review of the literature
Q48218793Predictive factors for live birth after in vitro maturation of oocytes in women with polycystic ovary syndrome.
Q93358265Rare genetic variants potentially involved in ovarian hyperstimulation syndrome
Q28084432Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic
Q38716011The high responder: a review of pathophysiology and outcomes during IVF treatment
Q47599593The number of oocytes retrieved during IVF: a balance between efficacy and safety
Q38954609The state of "freeze-for-all" in human ARTs
Q38677963What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study.
Q36378491Why more is less and less is more when it comes to ovarian stimulation

Search more.